Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd

$KIMSHospitalNSEBSE

Krishna Institute of Medical Sciences Ltd (KIMS) last traded at ₹772, a market capitalisation of ₹32,429 crore, on a P/E of 156. Over the past 52 weeks the stock has ranged between ₹576 and ₹858. Krishna Institute of Medical Sciences Ltd last reported results for the quarter ended Jun 2026, with sales of ₹1,180 crore and net profit of ₹37 crore. Krishna Institute of Medical Sciences Ltd’s annual general meeting is scheduled for 27 Aug 2026. Figures are as of 25 Aug 2026 and are not real time.

Krishna Institute of Medical Sciences Ltd share price and key metrics

Current price
₹772
Market cap
₹32,429 cr
Stock P/E
156
Book value
₹56.2
ROE
11.3%
ROCE
9.50%
Dividend yield
0.00%
52w high / low
858/576

Metrics as of 25 Aug 2026. Not real time.

Krishna Institute of Medical Sciences Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹1,180 cr, up 35.3% from ₹872 cr a year earlier. Net profit was ₹37 cr, down 56.5% year on year.

Krishna Institute of Medical Sciences Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales7777727978729619981,0751,180
Expenses559585599679757799868956
Operating profit218187198193204199206223
OPM %28%24%25%22%21%20%19%19%
Other income51815745117
Interest2026273345576883
Depreciation41455353667985101
Profit before tax16213513411497695557
Tax %26%31%21%25%26%24%40%34%
Net profit121921068572523337
EPS (₹)2.682.222.541.961.671.331.060.99

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Krishna Institute of Medical Sciences Ltd annual results

Krishna Institute of Medical Sciences Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,3301,6512,1982,4983,0353,9054,212
Operating profit377524611648793815833
OPM %28%32%28%26%26%21%20%
Net profit205344366336415242194
EPS (₹)5.198.328.417.759.616.035.05

TTM is the trailing twelve months to the most recent quarter.

Krishna Institute of Medical Sciences Ltd growth and returns

Compounded Sales Growth
10 Years
23%
5 Years
24%
3 Years
21%
TTM
31%
Compounded Profit Growth
10 Years
25%
5 Years
4%
3 Years
-9%
TTM
-43%
Stock Price CAGR
10 Years
%
5 Years
24%
3 Years
24%
1 Year
1%
Return on Equity
10 Years
18%
5 Years
18%
3 Years
15%
Last Year
11%

Krishna Institute of Medical Sciences Ltd shareholding pattern

Promoters held 32.49% at Jun 2026, down from 34.11% at Jun 2025. FIIs 14.75% and DIIs 34.42%.

Krishna Institute of Medical Sciences Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters38.82%38.82%38.82%34.11%34.11%34.11%34.11%32.49%
FIIs15.85%15.68%15.44%15.54%15.03%14.33%14.57%14.75%
DIIs32.29%32.05%31.95%31.65%32.12%32.72%32.50%34.42%
Public13.03%13.45%13.78%18.68%18.74%18.85%18.82%18.32%
No. of shareholders77,61795,4681,01,8951,08,9551,04,8721,01,59993,33394,730

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

When is Krishna Institute of Medical Sciences Ltd’s AGM?

Krishna Institute of Medical Sciences Ltd’s annual general meeting is scheduled for 27 Aug 2026.

  • AGM24th Annual General Meeting

See the full results calendar for every Indian company reporting in the next 30 days.

Krishna Institute of Medical Sciences Ltd corporate filings

  • KIMS has entered into Operations and Management agreement with Aurevia Hospitals Private LimitedCompany Updatemedium impact
    Filing PDF

    Cruxal's analysis: Krishna Institute of Medical Sciences (KIMS) has signed an Operations and Management…

    Read the full analysis
  • Allotment of WarrantsCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: The company has completed the formal allotment of warrants as part of its corporate…

    Read the full analysis
  • Transcript of earnings conference call with investors held on 04 August, 2026Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: KIMS Hospitals reported Q1 FY27 revenue of INR 1,196 crore, marking a 36.1% YoY growth…

    Read the full analysis
  • Intimation of receipt of the In-Principal Approval for the issue and allotment of warrants to promoters/promoters group on a preferential basisCompany Updatemedium impact
    Filing PDF

    Cruxal's analysis: Krishna Institute of Medical Sciences Limited (KIMS) has secured in-principle approval…

    Read the full analysis
  • Copy of Newspaper Publication towards intimation of notice of 24th Annual General Meeting of the Company.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Krishna Institute of Medical Sciences Ltd has published a newspaper notice regarding the…

    Read the full analysis
  • Emkay Confluence 2026Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Krishna Institute of Medical Sciences Ltd (KIMS) has announced its participation in the…

    Read the full analysis
  • Newspaper Publication on the unaudited financial results for 01st quarter ended 30th June, 2026.Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: Krishna Institute of Medical Sciences Limited has reported its consolidated financial…

    Read the full analysis
  • Audio Recording of Conference Call with Investors/ Analysts for Q1 FY27.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Krishna Institute of Medical Sciences Ltd (KIMS) has announced the availability of the…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Krishna Institute of Medical Sciences Ltd

Cruxal reads every Krishna Institute of Medical Sciences Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Krishna Institute of Medical Sciences Ltd (KIMS) Results, Financials & Share Price | Cruxal